Policyholder Services

Will my OMIC policy cover me for using Restylane?

On December 12, 2003, Medicis received FDA approval to market Restylane in the United States. In recognition of the filler’s FDA approval status, OMIC will extend coverage to physicians who use Restylane for the correction of facial wrinkles and/or lip augmentation. OMIC also offers a sample Restylane consent form, developed by Dr. John Shore, a member of OMIC’s Underwriting and Risk Management Committees and practicing oculoplastic surgeon.

Click here for sample Consent for Restylane Injection form.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

#2. Leader in the industry.

A-rated by AM Best, OMIC is ranked #1 among 50 malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined and operating ratios, the two most relevant financial measurements for an insurance carrier.